Tissue Regenix
Publicly traded British manufacturer of regenerative medicine wound care and orthopedic biologics.
Updated Jul 1, 2026
Headquartered in United Kingdom
This profile is compiled from public information and hasn't been claimed yet. Are you part of this company?
Overview
About Tissue Regenix
Tissue Regenix manufactures regenerative wound care biologics and decellularized tissue products used in orthopedic and wound care procedures, and is publicly traded, headquartered in Leeds, United Kingdom.
Products
- Regenerative wound care biologics
- Decellularized tissue products for orthopedics
Markets Served
Verification
Verification status
Last verified: Never
History
No verification history yet — this profile has not been claimed or submitted for review.
Verification requirements
Business registration document
A government-issued certificate of incorporation or business license.
Authorized company contact
A named contact with an email at the company's own domain.
Quality certification proof
Evidence of ISO 13485 or equivalent quality management certification.
Product catalog or line cardOptional
A current listing of manufactured product lines.
Why verify
What verification unlocks
Verification is how GHMAP tells buyers a profile is real and current — and how a company moves from being listed to being found first.
| Benefit | VerifiedSelf-service | Premium VerifiedPaid plan | GHMAP PartnerGHMAP-granted | GHMAP CertifiedGHMAP-granted |
|---|---|---|---|---|
| Priority search ranking | ||||
| Lead generation | ||||
| Verification indicators | ||||
| Premium visibility | ||||
| Future marketplace participation |
Related
Certifications
ISO 13485
The international quality management system standard specific to medical device manufacturers, referenced by most major regulators.
View →
CE Mark
The conformity mark required to sell medical devices in the EU/EEA, issued once a device meets EU MDR or IVDR requirements.
View →
FDA 510(k) / PMA
US market authorization for medical devices via the FDA's 510(k), De Novo, or PMA pathways.
View →
UKCA
The UK's post-Brexit conformity mark for the Great Britain market, overseen by the MHRA.
View →
Related
Regulatory Pathways
Opportunity Marketplace
Have a distributor search, tender, or other opportunity involving Tissue Regenix?
Submit it for GHMAP review — publication happens only after explicit admin approval.
Reviewed launch planning
Ready to connect with Tissue Regenix?
GHMAP routes introduction requests through a reviewed process — no cold outreach, no unverified contact details.
Professional review remains part of the workflow.